Evotec (EVO)
(Delayed Data from NSDQ)
$4.55 USD
-0.01 (-0.22%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $4.52 -0.03 (-0.66%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth F Momentum D VGM
Price, Consensus and EPS Surprise
EVO 4.55 -0.01(-0.22%)
Will EVO be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for EVO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EVO
Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J
EVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for EVO
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Evotec SE: Results of the Annual General Meeting 2024
Embark Education Continues Expansion in Australia
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Harding Loevner International Small Companies Equity Composite Q1 2024 Report